Europe Anti-obesity Medication Market Size & Outlook

The anti-obesity medication market in Europe is expected to reach a projected revenue of US$ 24,546.9 million by 2030. A compound annual growth rate of 41.3% is expected of Europe anti-obesity medication market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,183.7
Forecast, 2030 (US$M)
$24,546.9
CAGR, 2024 - 2030
41.3%
Report Coverage
Europe

Europe anti-obesity medication market, 2018-2030 (US$M)

Europe

Europe anti-obesity medication market highlights

  • The Europe anti-obesity medication market generated a revenue of USD 2,183.7 million in 2023.
  • The market is expected to grow at a CAGR of 41.3% from 2024 to 2030.
  • Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 2,183.7 million
Market revenue in 2030USD 24,546.9 million
Growth rate41.3% (CAGR from 2023 to 2030)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentation
Key market players worldwideNovo Nordisk A/S ADR, GlaxoSmithKline, Novartis AG ADR, Icahn Enterprises LP Depositary Units Repr Units of LP Interests, Rhythm Pharmaceuticals Inc, PureTech Health PLC

Other key industry trends

  • In terms of revenue, Europe region accounted for 33.0% of the global anti-obesity medication market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 19,116.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anti-obesity Medication Market Scope

Anti-obesity Medication Market Companies

Name Profile # Employees HQ Website

Europe anti-obesity medication market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-obesity medication market will help companies and investors design strategic landscapes.


Reasons to subscribe to Europe anti-obesity medication market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe anti-obesity medication market databook

  • Our clientele includes a mix of anti-obesity medication market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe anti-obesity medication market , including forecasts for subscribers. This continent databook contains high-level insights into Europe anti-obesity medication market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe anti-obesity medication market

Europe Anti-obesity Medication Market Outlook Share, 2023 & 2030 (US$M)

Europe anti-obesity medication market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more